Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.
Here are today's top performing health care Small-Cap Stars:
Fonar Corporation (FONR)
Fonar Corporation gained 8.37% to $11.40. The gains came on a volume of 90,197 shares against an average daily volume of 66,127 shares. Fonar Corporation has had a trading range from $27.95 to $5.12 over the last year, its P/E ratio is 6.2, it has a 50-day SMA of $11.77, and a 200-day SMA of $16.15.
Fonar Corp is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases.
Aratana Therapeutics Inc. (PETX)
Aratana Therapeutics Inc. gained 6.92% to $11.12. The gains came on a volume of 223,922 shares against an average daily volume of 179,310 shares. Aratana Therapeutics Inc. has had a trading range from $29.32 to $8.07 over the last year, it has a 50-day SMA of $13.95, and a 200-day SMA of $17.05.
Aratana Therapeutics Inc is a development-stage biopharmaceutical company. It is engaged in licensing, development and commercialization of prescription medicines for pets.
Anacor Pharmaceuticals Inc. (ANAC)
Anacor Pharmaceuticals Inc. gained 5.06% to $19.50. The gains came on a volume of 856,579 shares against an average daily volume of 569,040 shares. Anacor Pharmaceuticals Inc. has had a trading range from $23.07 to $7.65 over the last year, its P/E ratio is 11.7, it has a 50-day SMA of $16.83, and a 200-day SMA of $16.89.
Anacor Pharmaceuticals Inc is engaged in the discovery, development and commercialization of novel small molecule therapeutics derived from its novel boron chemistry platform.
Biolase Inc (BIOL)
Biolase Inc gained 4.89% to $2.36. The gains came on a volume of 1,083,120 shares against an average daily volume of 246,293 shares. Biolase Inc has had a trading range from $3.53 to $1.14 over the last year, it has a 50-day SMA of $2.09, and a 200-day SMA of $2.24.
Biolase Inc is a biomedical company that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes dental imaging equipment.
Insys Therapeutics Inc (INSY)
Insys Therapeutics Inc gained 4.5% to $31.79. The gains came on a volume of 1,339,720 shares against an average daily volume of 542,258 shares. Insys Therapeutics Inc has had a trading range from $57.91 to $11.49 over the last year, its P/E ratio is 22.6, it has a 50-day SMA of $27.70, and a 200-day SMA of $32.87.
Insys Therapeutics, Inc is a commercial-stage specialty pharmaceutical company. It develops and commercializes supportive care products that target the unmet needs of cancer patients, with an initial focus on cancer supportive care.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.
Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.
All data provided by QuoteMedia and was accurate as of 4:30 pm ET.